Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Named Innovator of the Year in 2026 BioTech Breakthrough Awards
Read More
GlobeNewswire
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
Read More
Endpoints News
Siren CEO named as a 2026 Endpoints News Women in Biopharma
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 11.7.26
Siren Biotechnology Named Innovator of the Year in 2026 BioTech Breakthrough Awards
Read More
Press Releases
|
Posted on 10.14.26
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
Read More
Media Coverage
|
Posted on 10.13.26
Siren CEO named as a 2026 Endpoints News Women in Biopharma
Read More
Press Releases
|
Posted on 6.26.26
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from CIRM to Support Clinical Development of SRN-101 in High-Grade Glioma
Read More
Media Coverage
|
Posted on 5.19.26
How a Biotech CEO Turned 1,600 Everyday Investors Into Backers—and Raised $4 Million
Read More
Press Releases
|
Posted on 4.24.26
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
Read More
Press Releases
|
Posted on 3.23.26
Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
Read More
Press Releases
|
Posted on 2.23.26
Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma
Read More
Press Releases
|
Posted on 1.28.26
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
Press Releases
|
Posted on 1.7.26
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Read More
1
2
3
…
6